tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC
Sweden Market

Elicera Therapeutics AB (ELIC) Financial Statements

Compare
1 Followers

Elicera Therapeutics AB Financial Overview

Elicera Therapeutics AB's market cap is currently €250.93M. The company's EPS TTM is kr-0.219; its P/E ratio is ―; Elicera Therapeutics AB is scheduled to report earnings on April 29, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 7.13Mkr 11.23Mkr 1.28Mkr 587.00kr 0.00
Gross Profitkr 7.13Mkr 11.22Mkr 1.27Mkr -11.19Kkr -11.78K
Operating Incomekr -16.88Mkr -17.10Mkr -19.36Mkr -13.12Mkr -2.83M
EBITDAkr -16.82Mkr -17.09Mkr -19.43Mkr -13.11Mkr -2.82M
Net Incomekr -16.11Mkr -16.40Mkr -19.52Mkr -13.12Mkr -2.82M
Balance Sheet
Cash & Short-Term Investmentskr 26.40Mkr 29.38Mkr 43.82Mkr 52.39Mkr 11.56M
Total Assetskr 27.56Mkr 30.18Mkr 46.31Mkr 54.74Mkr 12.59M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -26.40Mkr -29.38Mkr -43.82Mkr -52.39Mkr -11.56M
Total Liabilitieskr 6.79Mkr 13.78Mkr 13.51Mkr 2.50Mkr 2.35M
Stockholders' Equitykr 20.77Mkr 16.40Mkr 32.80Mkr 52.24Mkr 10.24M
Cash Flow
Free Cash Flowkr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -964.13K
Operating Cash Flowkr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -905.25K
Investing Cash Flowkr 0.00kr 483.17Kkr 0.00kr -1.00Kkr -8.88K
Financing Cash Flowkr 20.48Mkr 0.00kr 0.00kr 55.12Mkr 12.45M
Currency in SEK

Elicera Therapeutics AB Earnings and Revenue History

Elicera Therapeutics AB Debt to Assets

Elicera Therapeutics AB Cash Flow

Elicera Therapeutics AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis